Unleashing the Power of Innate Agonists: Precision Tumor Delivery via ADC Technology
- Exploring next-generation ADCs for precision delivery of innate agonist payloads
- Explaining how targeted delivery enables precise uptake and processing of ADCs by tumor-resident phagocytic immune cells, enabling strategic and localized payload release in the tumor microenvironment
- Assessing how robust activation of myeloid cells within the tumor microenvironment primes a potent adaptive anti-tumor immune response